Brought to you by:
Task Force to address question: How will we care for pediatric vascular patients?
Along with the American Pediatric Surgical Association (APSA), the Society for Vascular Surgery (SVS) plans to minimize and close some very real gaps in vascular care—treating pediatric patients. The two organizations have formed a joint task force on the issue…
In paying back, Joe Hart pays it forward
For Joe Hart, MD, a larger donation to the Society for Vascular Surgery (SVS) Foundation this past year is helping him pay back several of his own scholarships and research opportunities from which he benefited. “I’m someone who’s been fortunate…
Wei Zhou: Prepared for change—and a more diverse, vocal generation of surgeons
There was something of a different pulse to some of the matters around this year’s Western Vascular Society (WVS) annual meeting, recalls Wei Zhou, MD, a regular attendee over the last decade—particularly during a session dedicated to issues related to…
Venous disease: SVS DEI Committee seeks survey participants
The Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee is calling on vascular surgeons to complete a survey focused on patterns of practice in venous disease. Responses are due by Friday, Dec. 31. The committee seeks respondents…
Planning underway for next VAM
One of the innovations—livestreaming— introduced at the 2021 Vascular Annual Meeting (VAM), is influencing the 2022 schedule. “The streaming option, particularly for international members, was a big hit,” said Andres Schanzer, MD, chair of the Society for Vascular Surgery (SVS)…
Collaborative effort key to investigating potential biomarker of acute aortic syndrome
Research indicates that plasma desmosine has the potential to act as a biomarker of acute aortic syndrome and could, in the future, be used as a diagnostic tool for the condition in the acute setting. Presenting the findings of a British Heart…
VRIC 2022 to be held May 11 in Seattle
The Society for Vascular Surgery’s 2022 Vascular Research Initiatives Conference (VRIC) will return to its spring timeframe of the past several years. Abstract submission for VRIC closes at 6 p.m. Central Time Tuesday, Jan. 11, 2022. Registration opens Feb. 10,…
Smoking status ‘should not deter nor delay’ endovascular intervention in femoropopliteal vessels
Smoking does not seem to affect reocclusion rates, interval to reintervention and the total number of interventions in peripheral arterial disease (PAD) patients with stents in the femoropopliteal segment, new research showed. These were among the findings delivered by Sascha…
Surgeons must stay skilled in femorotibial/pedal bypass surgery, Paris audience hears
At Paris Vascular Insights (PVI) 2021 (Oct. 21–23, Paris, France), Peter Schneider, MD, University of California San Francisco, San Francisco, emphasized the need for trainees to learn both open and endovascular techniques in a talk on how to remain skilled…
PTFE crural bypasses: ‘Very acceptable patency, excellent limb salvage is obtainable with a fairly aggressive approach’
“The mantra I always use with fellows is bad vein, bad bypass.” Those were the words of Gregg Landis, MD, system chief of vascular surgery at Northwell Health in New York, as he presented an 18-year experience of polytetrafluoroethylene (PTFE)…